Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
- 1 March 2015
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 16 (3) , 274-283
Abstract
No abstract availableKeywords
Funding Information
- Dutch Cancer Society (KWF) ((CKTO 2006-08))
This publication has 31 references indexed in Scilit:
- Improved Clinical Outcomes With High-Dose Image Guided Radiotherapy Compared With Non-IGRT for the Treatment of Clinically Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- International Variation in Prostate Cancer Incidence and Mortality RatesEuropean Urology, 2012
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific IssuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Hypofractionated Intensity-Modulated Radiotherapy for Carcinoma of the Prostate: Analysis of ToxicityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancerEuropean Journal of Cancer, 2008
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate CancerJournal of Clinical Oncology, 2005
- The radiobiology of prostate cancer including new aspects of fractionated radiotherapyActa Oncologica, 2005